Related Experiment Videos

Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2

P J Tortolani1, J A Johnston, C M Bacon

  • 1Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892-1820, USA.

Blood
|June 15, 1995
PubMed

Insights

Thrombopoietin (TPO) signaling involves the c-Mpl receptor. This study reveals that TPO rapidly activates Janus kinase 2 (JAK2) in megakaryocytic cells, indicating JAK2

Area of Science:

  • Hematology
  • Molecular Biology
  • Cell Signaling

Background:

  • Thrombopoietin (TPO) regulates megakaryocyte and platelet production via the c-Mpl receptor.
  • The molecular mechanisms of TPO/c-Mpl signaling are not fully understood.
  • Janus kinases (JAKs) are implicated in signaling pathways of hematopoietin receptors.

Purpose of the Study:

  • To investigate the role of Janus kinases in TPO-mediated signal transduction.
  • To identify specific JAKs involved in TPO signaling in megakaryocytic cells.

Main Methods:

  • Utilized the M07e megakaryocytic cell line expressing c-Mpl.
  • Stimulated cells with TPO and analyzed protein phosphorylation.
  • Assessed Janus kinase activation using in vitro assays.

Main Results:

  • TPO induced tyrosine phosphorylation of substrates between 80-140 kD.
  • Specifically, TPO rapidly induced tyrosine phosphorylation of a 130-kD protein identified as Janus kinase 2 (JAK2).
  • No detectable tyrosine phosphorylation of JAK1, JAK3, or TYK2 was observed; TPO activated JAK2 phosphotransferase activity.

Conclusions:

  • JAK2 is a key mediator of TPO-induced signal transduction.
  • This finding elucidates a crucial step in the molecular mechanism of TPO/c-Mpl action.

Related Concept Videos